Blood serum analyses of depressed patients also show reduced BDNF levels before treatment, but additionally that these reduced levels can be rescued by antidepressant treatments, supporting that BDNF is a biomarker of depression and treatment response (Sen et al., 2008; Bocchio-Chiavetto et al., 2010). This evidence concerns the gene BDNF and depressive symptom measurement.